##
##
|Trustees||||H Matthews||||
|---|---|---|---|---|---|---|---|
|||||N Menezes||||
|||||N Mumford||||
|||||S Krag||||
|||||H Goodfellow||||
|||||L Condron||||
|||||D Georgiou||||
|||||R Legg||(Appointed|16 March 2020)|
|||||C Carter||(Appointed|1 April 2020)|
|||||E Cowan||(Appointed|24August 2021)|
|||||N Longworth||(Appointed|27August 2021)|
|||||L Nylander||(Appointed|24August 2021)|
|Secretary||||G Brown||||
|Charity number||(England|and Wales)|1137689||||
|Charity number||(Scotland)||SC049777||||
|Company|number|||07272699||||
|Registered|office|||Unit 9||||
|||||Oakhanger|Farm|Business Park||
|||||Oakhanger|Road|||
|||||Oakhanger||||
|||||Hampshire||||
|||||GU35 9JA||||
|Auditor||||Alliotts LLP||||
|||||Friary Court||||
|||||13-21 High|Street|||
|||||Guildford||||
|||||Surrey||||
|||||GU1 3DL||||
##
##
|||Page|
|---|---|---|
|CEO's Report||1-2|
|Trustees'
report||3-15|
|Statement
ofTrustees'|responsibilities|16|
|Independent
auditor's|report|17-20|
|Statement
offinancial|activities|21|
|Balance sheet||22|
|Statement
ofcash flows|||
|Notes to the financial|statements|24-37|
##
##
##
##
##
##
##
##
##
|Our mission|Our mission|Our mission||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Our mission
is to improve
survival
rates|||of pancreatic
cancer||by ensuring||more people are||||diagnosed|||early||
|and that everyone|has access to effective||treatments,
support,||information||and|care.||||||||
|Objectives||||||||||||||||
|The charity's
objectives are:||||||||||||||||
|A|Awareness|- increase|public|awareness|and|knowledge||of pancreatic|||cancer||and||its|
|symptoms|to achieve|early diagnosis||||||||||||||
|C|Campaign|and
lobby|the government
and||key|stakeholders||for|change||to advance||||the|
|standard|of healthcare|for individuals
affected by pancreatic||||cancer||||||||||
|T|Train
and|provide
pioneering||educational|resources||for|our|medical||and|healthcare||||
|communities||||||||||||||||
|I|Innovative|research
-|we fund|it, we support
it||- to improve||early diagnosis||||and|develop|||
|effective
0|treatments
to improve pancreatic
Offer the
provision
of practical|||cancer outcomes
and
emotional
support|||and|information||to all||affected|||by|
|pancreatic cancer||||||||||||||||
|N|Now- we are the action charity|||and action is needed more than ever before!||||||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|
|||funds|funds||funds|funds||
||Notes|2020|2020
f|2020
F|2019
F|2019f|2019
F|
|Income from:||||||||
|Donations
and legacies||532,104|623,639|1,155,743|734,707|12,345|747,052|
|Charitable
activities|||92,236|92,236|1,300|25,500|26,800|
|Other trading
activities||7,697||7,697|11,179||11,179|
|Investments||801||801|1,474||1,474|
|Total income||540,602|715,875|1,256,477|748,660|37,845|786,505|
|Ex enditure on:||||||||
|Raising funds||270,766|37,849|308,615|292,879||292,879|
|Charitable
activities||312,399|125,439|437,838|513,135|95,796|608,931|
|Total resources||||||||
|expended||583,165|163,288|746,453|806,014|95,796|901,810|
|Net (expenditure)/income||||||||
|for the year/||||||||
|Net movement
in funds||(42,563)|552,587|510,024|(57,354)|(57,951)|(115,305)|
|Fund balances at 1||||||||
|January 2020||351,966|67,947|419,913|409,320|125,898|535,218|
|Fund balances at 31||||||||
|December 2020||309,403|620,534|929,937|351,966|67,947|419,913|
##
##
##
||||2020||2019||
|---|---|---|---|---|---|---|
|||Notes|F||F||
|Fixed assets|||||||
|Tangible assets||13||18,571||34,086|
|Current assets|||||||
|Stocks||14|14,892||29,456||
|Debtors falling due|after one year|15|||12,990||
|Debtors falling due|within one year|15|113,325||71,349||
|Cash at bank and|in hand||840,651||306,960||
||||968,868||420,755||
|Creditors: amounts
falling due within|||||||
|one year||16|(57,502)||(34,928)||
|Net current assets||||911,366||385,827|
|Total assets less|current liabilities|||929,937||419,913|
|Income funds|||||||
|Restricted
funds||18||620,534||67,947|
|Unrestricted
funds|||||||
|Designated
funds||20|15,485||17,107||
|General
unrestricted
funds|||293,918||334,859||
|||||309,403||351,966|
|||||929,937||419,913|
##
##
##
|||||||2020||2019||
|---|---|---|---|---|---|---|---|---|---|
|||||Notes||||F||
|Cash flows from operating||activities||||||||
|Cash generated
from/(absorbed|||by)|25||||||
|operations|||||||532,890||(119,330)|
|Investing|activities|||||||||
|Purchase|oftangible
fixed assets|||||||(4,599)||
|Investment|income received||||801|||1,474||
|Net cash|generated
from/(used||in)|||||||
|investing|activities||||||801||(3,125)|
|Net cash|used in financing|activities||||||||
|Net increase/(decrease)
in||cash and||cash||||||
|equivalents|||||||533,691||(122,455)|
|Cash and|cash equivalents|at beginning||ofyear|||306,960||429,415|
|Cash and|cash equivalents|at end of||year|||840,650||306,960|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|
||||funds|funds||funds|funds||
|||||||as restated|||
||||2020|2020||2019|2019|2019|
|Donations|and gifts||501,104|623,639|1,124,743|707,221|12,345|719,566|
|Grants receivable for|||||||||
|core activities|||31,000||31,000|6,878||6,878|
|Donated|goods and||||||||
|services||||||20,608||20,608|
||||532,104|623,639|1,155,743|734,707|12,345|747,052|
|Charitable||activities|||||||
||||||Grants|Grants|Other|Total|
|||||||||2019|
||||||2020|2019|2019||
||||||F|F|F||
|Performance||related|grants||33,455|25,500||25,500|
|Government||Grant|||58,781||||
|Other income|||||||1,300|1,300|
||||||92,236|25,500|1,300|26,800|
|Analysis|by|fund|||||||
|Unrestricted||funds|||||1,300|1,300|
|Restricted|funds||||92,236|25,500||25,500|
##
|Unrestricted|Unrestricted|
|---|---|
|funds|funds|
||as restated|
||2019|
|7,697|11,179|
##
##
##
##
|||Unrestricted|Unrestricted|
|---|---|---|---|
|||funds|funds|
|||2020|2019|
|Interest|receivable|801|1,474|
||||Unrestricted|Restricted|Total|Unrestricted|
|---|---|---|---|---|---|---|
||||funds|funds||funds|
||||2020|2020|2020|2019|
|Fundraisin|and|ublici|||||
|Advertising|||2,508||2,508|2,892|
|Other fundraising||costs|44,265||44,265|85,631|
|Staff costs|||165,990|37,849|203,839|147,998|
|Depreciation|and|impairment|5,096||5,096|4,824|
|Support costs|||37,103||37,103|41,266|
|Fundraising|and|publicity|254,962|37,849|292,811|282,611|
|TTradin t costs|||||||
|Other trading|activities||15,804||15,804|10,268|
||||270,766|37,849|308,615|292,879|
##
##
##
|||||Raising|Supporting|Medical|Patient|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||awareness|research|education|support/|2020|2019|
||||||||information|||
|||||||2020|2020|||
|||||||F|F|||
|Staff costs||||133,330|39,581|18,624|39,759|231,294|319,279|
|Depreciation||and||||||||
|impairment||||5,982|1,817|836|1,784|10,419|10,406|
|Other costs||||67,989|21,418|9,848|21,024|120,279|217,516|
|||||207,301|62,816|29,308|62,567|361,992|547,201|
|Share ofsupport costs||||||||||
|(see note|9)|||34,428|10,459|4,809|10,267|59,963|51,239|
|Share ofgovernance|||costs|||||||
|(see note|9)|||9,119|2,770|1,274|2,720|15,883|10,491|
|||||250,848|76,045|35,391|75,554|437,838|608,931|
|Analysis|by|fund||||||||
|Unrestricted||funds||181,974|52,981|26,558|50,886|312,399|513,135|
|Restricted|funds|||68,874|23,064|8,833|24,668|125,439|95,796|
|||||250,848|76,045|35,391|75,554|437,838|608,931|
##
##
##
##
##
|||||Raising|Supporting|Medical|Patient|Total|
|---|---|---|---|---|---|---|---|---|
|||||awareness|research|education|support/|2019|
||||||||information||
|||||F|F|F|F||
|Staff costs||||172,223|85,142|53,272|8,642|319,279|
|Depreciation||and impairment||5,613|2,775|1,736|282|10,406|
|Other costs||||114,989|56,185|41,982|4,360|217,516|
|||||292,825|144,102|96,990|13,284|547,201|
|Share of|support costs (see note 9)|||27,639|13,664|8,549|1,387|51,239|
|Share of|governance||costs (see note 9)||||||
|||||5,660|2,797|1,750|284|10,491|
|||||326,124|160,563|107,289|14,955|608,931|
|Analysis|by|fund|||||||
|Unrestricted||funds||237,669|155,563|107,289|12,614|513,135|
|Restricted|funds|||88,455|5,000||2,341|95,796|
|||||326,124|160,563|107,289|14,955|608,931|
##
##
##
|Support|cost|s||||||||
|---|---|---|---|---|---|---|---|---|---|
|||||Support|Governance|2020|Support|Governance|2019|
|||||costs|costs||costs|costs||
||||||||F|||
|Rent||||48,062||48,062|42,214||42,214|
|Office costs||||3,076||3,076|7,253||7,253|
|Telephone|costs|||6,589||6,589|5,925||5,925|
|Computer|costs|||21,609||21,609|16,347||16,347|
|Insurance||||3,758||3,758|383||383|
|Training,|recruitment||and|||||||
|internship|costs|||1,988||1,988|10,416||10,416|
|Book-keeping||and||||||||
|Accountancy||||1,747||1,747|1,687||1,687|
|Bank charges||||2,468||2,471|3,418||3,418|
|Audit fees|||||6,960|6,960||3,288|3,288|
|Legal and|professional||||16,692|16,692||12,065|12,065|
|||||89,297|23,652|112,952|87,643|15,353|102,996|
|Analysed|between|||||||||
|Fundraising||||29,334|7,769|37,103|36,404|4,862|41,266|
|Charitable|activities|||59,963|15,883|75,846|51,239|10,491|61,730|
|||||89,297|23,652|112,949|87,643|15,353|102,996|
##
##
##
##
|11|Employees||(Continued)|
|---|---|---|---|
||Employment
costs|2020|2019|
|||F|F|
||Wages and salaries|392,647|421,215|
||Social security costs|31,655|37,483|
||Other pension costs|10,831|8,579|
|||435,133|467,277|
|more we|re:|||
|---|---|---|---|
|||2020|2019|
|||Number|Number|
|F60,000|- F70,000||1|
##
##
|Tangible fixed assets|||||
|---|---|---|---|---|
|||Fixtures,|Computers|Total|
|||fittings
&|||
|||equipment|||
|Cost|||||
|At 1 January 2020||31,237|41,911|73,148|
|At 31 December 2020||31,237|41,911|73,148|
|Depreciation
and impairment|||||
|At 1 January 2020||15,123|23,939|39,062|
|Depreciation
charged|in the year|7,255|8,260|15,515|
|At 31 December 2020||22,378|32,199|54,577|
|Carrying
amount|||||
|At 31 December 2020||8,859|9,712|18,571|
|At 31 December 2019||16,114|17,972|34,086|
##
##
##
|14|Stocks|||||
|---|---|---|---|---|---|
|||||2020|2019|
|||||F|F|
||Finished goods and goods for resale|||14,892|29,456|
|15|Debtors|||||
|||||2020|2019|
||Amounts
falling due||within one year:|||
||Other debtors|||278|178|
||Prepayments|and accrued income||113,047|71,171|
|||||113,325|71,349|
|||||2020|2019|
||Amounts
falling due||after more than one year:|||
||Prepayments|and accrued income|||12,990|
||Total debtors|||113,325|84,339|
|16|Creditors: amounts||falling due within one year|||
|||||2020|2019|
||Other taxation|and social security||30,432|12,046|
||Trade creditors|||(6)|19,136|
||Accruals and|deferred|income|27,076|3,746|
|||||57,502|34,928|
##
##
##
##
##
||||Movement|in funds|||Movement|in funds||
|---|---|---|---|---|---|---|---|---|---|
|||Balance at|Incoming|Resources|Balance at||Incoming|Resources|Balance at|
|||1 January 2019|resources|expended1|January|2020|resources|expended|31 December|
||||||||||2020|
|Pat 8 Paul||8,769|897|(9,666)|||1,366||1,366|
|Early||||||||||
|diagnosis||||||||||
|challenge||||||||||
|award||||||||||
|(research)|||5,000|(5,000)||||||
|POW app||17,200|||17,200||||17,200|
|Recipe Book||22,451||(2,341)|20,110||||20,110|
|Noel||41,784||(41,784)||||||
|Patient||||||||||
|Information||||||||||
|Booklets||31,724||(4,587)|27,137|||(9,150)|17,987|
|Awards
for|all|3,670||(3,670)||||||
|Hope is||||||||||
|Contagious||300|190|(490)|||6||6|
|NIPanC|||13,258|(13,258)|||14,706|(8,250)|6,456|
|PCAware|Nl||15,000|(15,000)||||||
|PCAware||||||||||
|Wales|||3,500|||3,500|24,245||27,745|
|Hard to reach||||||||||
|gr'oups|||||||6,000||6,000|
|Pancreatic||||||||||
|Cancer||||||||||
|Scotland|||||||607,560|(87,106)|520,454|
|HMRC JRS||||||||||
|Grant|||||||58,782|(58,782)||
|Health||||||||||
|information||||||||||
|officer|||||||2,250||2,250|
|Community||||||||||
|volunteers|||||||960||960|
|||125,898|37,845|(95,796)|67,947||715,875|(163,288)|620,534|
##
|19|Analysis of net assets|between funds||||||
|---|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|||2020|2020|2020|2019|2019|2019|
|||F|F|F|F|F|F|
||Fund balances at 31|||||||
||December 2020 are|||||||
||represented
by:|||||||
||Tangible assets|18,571||18,571|34,086||34,086|
||Current assets/|||||||
||(liabilities)|290,832|620,534|911,366|317,880|67,947|385,827|
|||309,403|620,534|929,937|351,966|67,947|419,913|
##
|The income|funds|funds|of the|charity|include|the following|designated|funds|funds|which|which|have|been set|aside out of|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|unrestricted|funds||by the|trustees|for specific purposes:||||||||||
|||||||Movement|in funds||||||||
|||||Balance at||Incoming|Resources|||Balance||at|Resources|Balance at|
|||||1 January 2019||resources|expended1||January||2020||expended|31 December|
|||||||||||||||2020|
|||||||||||||||F|
|Early diagnosis||challenge|||||||||||||
|award (research)|||||73,292||(56,185)|||17,107|||(1,622)|15,485|
|Core costs||||||8,878|(8,878)||||||||
||||||73,292|8,878|(65,063)|||17,107|||(1,622)|15,485|
##
##
##
##
##
##
##
|||||||||||2020|2019|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||F|F|
||Aggregate
compensation|||||||||42,512|68,890|
||The key management|personnel|ofthe||Charity||is considered||to be the CEO.|||
||There were no other related
party|||transactions.||||||||
|25|Cash generated
from|operations||||||||2020|2019|
|||||||||||F|F|
||Surplus/(deficit)
for the|year||||||||510,024|(115,305)|
||Adjustments
for:|||||||||||
||Investment
income recognised||in|statement||offinancial||activities||(801)|(1,474)|
||Depreciation
and impairment
oftangible||||fixed assets|||||15,515|15,230|
||Movements
in working|capital:||||||||||
||Decrease/(increase)
in|stocks||||||||14,564|(872)|
||(Increase)
in debtors|||||||||(28,986)|(7,049)|
||Increase/(decrease)
in|creditors||||||||22,574|(9,860)|
||Cash generated
from/(absorbed|||by) operations||||||532,890|(119,330)|
##
##
##